562
L. V. Reddy, M. Nakka, A. Suman, S. Ghosh, M. Helliwell, K. Mukkanti, A. K. Mukherjee,
and S. Pal
Vol 48
[2] Karakuꢀs, S.; Ku¨c¸u¨kgu¨zel, S. G.; Ku¨c¸u¨kgu¨zel, I.; Clercq, E.
D.; Pannecouque, C.; Andrei, G.; Snoeck, R.; Sꢀahin, F.; Bayrak, O. F.
Eur J Med Chem 2009, 44, 3591.
N-(2-Chloro-3-[(2-(2-(2,3-dimethylphenylamino)benzoyl)hy-
drazono)methyl]-7-phenoxyquinolin-6-yl)methanesulfonamide
(6b). Light yellow solid; Rf 0.65 (CHCl3 : EtOAc 9:1); mp
202–204ꢀC; 1H NMR (300 MHz, DMSO-d6) d 12.3 (1H, s,
D2O exchangeable, NH), 10.5 (1H, s, D2O exchangeable, NH),
9.4 (1H, s, D2O exchangeable, NH), 9.0 (1H, s, ArH), 8.90
(2H, m, ArH), 8.50 (1H, s, ArH), 7.8 (1H, d, J ¼ 8.8 Hz,
ArH), 7.15 (11H, m, ArH þ ACH¼¼), 3.7 (3H, s, SO2CH3),
2.4 (3H, s, CH3) 2.2 (3H, s, CH3); IR (KBr, cmꢂ1) 2869,
1687, 1620, 1555; MS (m/z, CI method) 614 (Mþ, 100%).
Elemental Analysis found: C, 62.50; H, 4.65; N, 11.48
C32H28ClN5O4S Requires: C, 62.58; H, 4.60; N, 11.40.
´
[3] Michaux, C.; Charlier, C.; Julemont, F.; Leval, X. de;
´
Dogne, J.–M.; Pirotte, B.; Durant, F. Eur J Med Chem 2005, 40, 1316.
[4] Kidwai, M.; Negi, N. Monatshefte ffir Chemie 1997, 128, 85.
[5] Nagaraja, G. K.; Prakash, G. K.; Kumaraswamy, M. N.;
Vaidya, V. P.; Mahadevan, K. M. ARKIVOC 2006, xv, 160.
[6] Pericherla, S.; Mareddy, J.; Geetha, R. D. P.; Gollapudi, P.
V.; Pal, S. J Braz Chem Soc 2007, 18, 384.
´ ´
[7] Kouznetsov, V. V.; Mendez, L. Y. V.; Gomez, C. M. M.
Curr Org Chem 2005, 9, 141.
[8] Marson, C. M.; Giles, P. R. Synthesis using Vilsmeier
Reagents; CRC: Boca Raton, 1994.
N-(2-Chloro-3-[(2-(2-hydroxybenzoyl)hydrazono)methyl]-7-
phenoxyquinolin-6-yl)methanesulfonamide (6c). Cream col-
ored solid; Rf 0.62 (CHCl3 : EtOAc 9:1); mp 218–220ꢀC; 1H
NMR (300 MHz, DMSO-d6) d 10.5 (1H, s, D2O exchangeable,
NH), 9.9 (1H, s, D2O exchangeable, NH), 9.1 (2H, m, ArH),
8.90 (1H, s, ArH), 8.50 (1H, s, ArH), 8.2 (s, 1H, ArH), 7.87
(1H, d, J ¼ 8.8 Hz, ArH), 7.5 (2H, m, ArH), 7.30 (3H, m,
ArH), 7.15 (2H, d, J ¼ 8.8 Hz, ArH), 6.9 (1H, s, ACH¼¼), 3.8
(3H, s, SO2CH3); IR (KBr, cmꢂ1) 3377, 2923, 1678, 1605;
MS (m/z, CI method) 511 (Mþ, 100%).
[9] Meth-Cohn, O.; Taylor, D. L. Tetrahedron 1995, 51, 12869.
[10] Crystallographic data (excluding structure factors) for the
structures reported in this paper have been deposited with the Cam-
bridge Crystallographic Data Centre as supplementary publication no.
CCDC 734903. Copies of available material can be obtained, free of
quest@ccdc.cam.ac.uk, or contacting the Cambridge Crystallographic
Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: Þ44
1223 336033.
¨
[11] Sheldrick, G. M. CELL_NOW, 2002; University of Gottin-
gen, Germany.
[12] Sheldrick, G. M. SHELXS 97 and SHELXL 97, 1997; Uni-
Elemental Analysis found: C, 56.49; H, 3.74; N, 10.90
C24H19ClN4O5S Requires: C, 56.42; H, 3.75; N, 10.97.
X-ray crystallographic study of N-(2-chloro-3-formyl-7-
phenoxy quinolin-6-yl)formamide (3). Molecular formula
C17O3N2H11Cl, M ¼ 326.7, triclinic, space group P-1, a ¼
¨
versity of Gottingen, Germany.
[13] Farrugia, L. J. J Appl Cryst 1997, 30, 565.
[14] Palani, K.; Ambalavanan, P.; Ponnuswamy, N. N. G.;
Yathirajan, H. S.; Prabhuswamy, B.; Raju, C. R.; Nagaraja, P.; Shashi-
kanth, S. Anal Sci 2004, 20, 403.
˚
5.3015(9), b ¼ 9.0196(19), c ¼ 15.454(4) A, a ¼ 99.011(4), b
3
ꢀ
˚
¼ 92.710(4), c ¼ 93.355(2) , V ¼ 727.4(4) A , Z ¼ 2, F(000)
¼ 336, T ¼ 150 (2)K, k ¼ 0.6945 A, Dc ¼ 1.492 Mg mꢂ3, l
˚
[15] Somvanshi, R. K.; Subashini, R.; Dhanasekaran, V.; Arul-
prakash, G.; Das, S.; Dey, S. J. Chem Crystallogr 2008, 38, 381.
[16] Kalkhambkar, R. G.; Kulkarni, G. M.; Hwang, W.-S.; Lee,
C.-S. Acta Cryst 2008, E64, 0258.
¼ 0.280 mmꢂ1, Final R1 ¼ 0.0540, WR2 ¼ 0.1219, S ¼ 1.100
for 2968 reflections; for 2578 observed reflections [I> 2r (I)]
R1 ꢂ¼3 0.0486, WR2 ¼ 0.1165, Dqmax/Dqmin ¼ 0.447/ꢂ0.456
˚
eA
[17] Rajendran, P.; Karavembu, R. Ind J Chem 2002, 41B, 222.
[18] Dutta, N. J.; Khunt, R. C.; Parikh, A. R. Ind J Chem 2002,
41B, 433.
Acknowledgment. S.P. thank M. N. Raju, the chairman of
M.N.R. Educational Trust for his constant encouragement. S.G.
thank Jadavpur University and Government of West Bengal for
the research fellowship.
[19] Bu¨rgi, H.-B.; Dunitz, J. D., Eds. Structure Correlation,
Vol. 2.; Weinheim, Verlag VCH: New York, 1994, p 771.
[20] Cheng, H.-M.; Zhu, D.-R.; Lu, W.; Xu, R.-H.; Shen, X. J.
Heterocyclic Chem 2010, 47, 210.
[21] Blackburn, A. C.; Dobson, A. J.; Gerkin, R. E. Acta Cryst
1996, C52, 409.
[22] Chiang, L. Y.; Swirczewski, J. W.; Kastrup, R.; Hsu, C. S.;
Upasani, R. B. J Am Chem Soc 1991, 113, 6574.
[23] Gdaniec, M.; Jaskolski, M.; Kosturkiewicz, Z. Polym J
Chem 1980, 54, 1539.
REFERENCES AND NOTES
[1] Roberts, L. J.; Morrow, J. D. Analgesic-antipyretic and
anti-inflammatory agents and drugs employed in the treatment of gout,
in Goodman & Gilman’s the pharmacological basis of therapeutics;
Hardman, J. G.; Limbird, L. E., Eds.; McGraw-Hill, New York, 2001;
pp 687–731.
[24] Gdaniec, M.; Dziembowska, T. Polym J Chem 1980, 54, 87.
[25] Ahmet, M. T.; Miller, J. R.; Osborne, A. G.; Warmsley, J.
F. Acta Cryst 1995, C51, 2105.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet